Blood test to track tumor markers across cancer types
Part of Cancer, Lungs & breathing clinical trials.
This trial studies a blood test that looks for circulating tumor markers in people with any type of invasive cancer (newly diagnosed or suspected). The goal is to see if markers in the blood can help monitor the cancer and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have or be suspected of having an invasive cancer, at any stage or location.
- You must be 18 years or older.
- You must sign a consent form and have French health insurance.
- If a tumor biopsy is done: the tumor must be reachable for biopsy, your blood clotting tests must be normal, and you cannot be on blood thinners.
- You cannot be pregnant or breastfeeding.
- You cannot have had another invasive cancer within the past 5 years (except for certain types).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This study uses blood samples to look for tiny pieces of cancer cells called circulating tumor cells. Your results may help researchers understand how cancer cells spread and how cancer could be monitored over time.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.